Visit our COVID-19 Experts Directory to find UC San Diego sources who are available to discuss with the media the novel coronavirus, the COVID-19 illness and the societal impacts of the pandemic.
A UC San Diego-led program that monitors wastewater for the presence of SARS-CoV-2 and which has effectively predicted subsequent surges in COVID-19 cases in San Diego has been expanded to detect the presence of monkeypox.
Researchers at University of California San Diego School of Medicine and Rady Children’s Hospital-San Diego have joined a nationwide study to better understand the long-term impact of COVID-19 on patients in the United States across all demographic groups.
New UC San Diego Rady School of Management study is first to track smoking behavior at the individual level during the pandemic.
Health care facilities in Black metropolitan counties, Hispanic rural counties and hardest-hit counties were less likely to administer COVID-19 vaccines during initial rollout, UC San Diego study finds.
In a pair of related studies, UC San Diego researchers show that the origin of the COVID-19 pandemic was at a Chinese market and resulted from at least two instances of the SARS-CoV-2 virus jumping from live animal hosts to humans working or shopping there.
UC San Diego researchers describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.
UC San Diego researchers provide first insights into the fundamental cellular pathologies that drive interstitial lung disease in patients post-COVID.
Scientists and physicians at UC San Diego and Scripps Research describe how wastewater sequencing provided dramatic new insights into levels and variants of SARS-CoV-2 on campus and in the broader community — a key step to public health interventions in advance of COVID-19 case surges.
A $10 million grant over four years will support further examination of a national study looking at COVID-19 vaccination safety during pregnancy and immune response pre-and post-delivery for both mom and baby.
COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, UC San Diego researchers find after showing rebound patient did not show drug resistance or impaired immunity.